Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;8(6):1056-1064.
doi: 10.21037/jgo.2017.08.17.

Contrast enhanced ultrasound guided biopsies of liver lesions not visualized on standard B-mode ultrasound-preliminary experience

Affiliations

Contrast enhanced ultrasound guided biopsies of liver lesions not visualized on standard B-mode ultrasound-preliminary experience

Sasan Partovi et al. J Gastrointest Oncol. 2017 Dec.

Abstract

Background: To assess the technical success of contrast enhanced ultrasound (CEUS) guided biopsies of liver lesions poorly visualized on B-mode ultrasound.

Methods: Patients were selected during the procedure based on the real-time clinical scenario of unsatisfactory B-mode ultrasound lesion visualization and all patients would have otherwise undergone CT guided liver lesion biopsy. A total of 26 patients underwent CEUS guided biopsy and were included in this retrospective analysis. The review of the patients' files included demographic information, lesion characteristics on imaging, procedural details and pathology outcome. Technical success was defined as concordance between the radiological findings, pathology report and clinical follow-up-demonstrating lack of need for re-biopsy or re-biopsy with identical pathological results. Patients with less than 2 months follow-up were excluded from the study.

Results: CEUS guided liver biopsy was successful in 23 out of 26 patients (88.5%). The average procedure time was 30.7±12.3 minutes and the average lesion size was 2.2±1.7 cm. The majority of lesions (80.8%) were hypoenhancing on the delayed phase of CEUS. The mean number of samples taken from each lesion per procedure was 3.2 (±1.7).

Conclusions: CEUS guidance biopsies of focal liver lesions (FLL) that were difficult to visualize on B-mode ultrasound demonstrated high success rate and may be an evolving image guidance modality in selected patients to avoid CT guided procedures.

Keywords: Contrast-enhanced ultrasonography (CEUS) guided interventions; liver lesions.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The results of the paper were partially presented as oral talk at the Society of Interventional Radiology 2017 Annual Meeting in Washington, DC in March 2017 and at the Digestive Disease Intervention Meeting 2016 in San Diego, CA in October 2016.

Figures

Figure 1
Figure 1
Patient #4. A 53-year-old male with metastatic colorectal carcinoma presented with a new hypodense liver lesion in segment 4A on CT, measuring 1.8×1.5 cm (A); CT/US fusion was attempted but did not significantly improve lesion visualization (B,C); the lesion revealed to be mildly hypoechoic on B-mode ultrasound (D); after intravenous Definity contrast administration, the lesion demonstrated lower enhancement on the delayed phase in comparison to the surrounding liver parenchyma, making it clearly visible and facilitated biopsy (E). Pathology demonstrated metastatic adenocarcinoma consistent with colonic primary.
Figure 2
Figure 2
Patient #5. A 69-year-old male with a history of hepatitis C and HCC, presented with two heterogeneous predominantly hypodense new liver lesions in segments 5 and 7 on CT (A,B), which were not visualized on B-mode ultrasound (C); the lesion in segment 5 measured 1.8 cm and the lesion in segment 7 measured 1.6 cm. After contrast administration, the lesions were well demarcated from surrounding enhancing parenchyma and both lesions showed irregular margins without significant contrast enhancement (D). CEUS guided biopsy was performed for the 1.6 cm lesion located in segment 7. Pathology demonstrated malignant cells compatible with poorly differentiated adenocarcinoma. HCC, hepatocellular carcinoma; CEUS, contrast enhanced ultrasound.
Figure 3
Figure 3
Patient #21. A 66-year-old male with history of gastric adenocarcinoma presented with a new hypodense lesion in segment 5 of the liver based on CT (A); on B-mode US the lesion is mildly hypoechoic and almost invisible (B); after contrast injection, the lesion is hypoenhancing with clear delineation of the lesion borders (C). Pathology confirmed metastatic disease from gastric adenocarcinoma.
Figure 4
Figure 4
Patient #24—a 74-year-old male with history of hepatocellular carcinoma and colorectal carcinoma. Patient underwent radiofrequency ablation of a liver lesion in segment 4A previously, and now came back with suspected local recurrence. The ablation area is visible on CT (A) as a hypodense area; FDG-PET/CT (B) demonstrates mild peripheral metabolic activity; on B-mode US the lesion appears as subtle hypoechoic (C) and after contrast injection the area is hypoenhancing with superior delineation of the lesion borders (D). Pathology excluded recurrent disease and this is concordant with the imaging findings of a hypodense FLL on CT with mild peripheral hypermetabolism on FDG-PET/CT. FLL, focal liver lesions.

References

    1. Spârchez Z, Radu P, Kacso G, et al. Prospective comparison between real time contrast enhanced and conventional ultrasound guidance in percutaneous biopsies of liver tumors. Med Ultrason 2015;17:456-63. - PubMed
    1. Catalano O, Nunziata A, Lobianco R, et al. Real-time harmonic contrast material-specific US of focal liver lesions. Radiographics 2005;25:333-49. 10.1148/rg.252045066 - DOI - PubMed
    1. Cresswell AB, Welsh FK, Rees M. A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy? HPB (Oxford) 2009;11:533-40. 10.1111/j.1477-2574.2009.00081.x - DOI - PMC - PubMed
    1. Huang GT, Sheu JC, Yang PM, et al. Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma--a study based on 420 patients. J Hepatol 1996;25:334-8. 10.1016/S0168-8278(96)80120-6 - DOI - PubMed
    1. Durand F, Regimbeau JM, Belghiti J, et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 2001;35:254-8. 10.1016/S0168-8278(01)00108-8 - DOI - PubMed

LinkOut - more resources